Analyst firms · H.C. Wainwright · EXEL

H.C. Wainwright EXEL price target and rating history

Exelixis Inc. (EXEL) · Health Care

H.C. Wainwright rates Exelixis Inc. (EXEL) Buy with a $28 price target, as of its latest action on Sep 26, 2023. It has published 4 rating actions on EXEL since August 2021, including 0 upgrades and 0 downgrades. Across 5 firms with a EXEL price target in the last 12 months, the median target is $52.

Current rating
Buy
Price target
$28
Median target, all firms
$52
Actions on EXEL
4

H.C. Wainwright price target on EXEL

$64$46$2820222023202420252026
H.C. Wainwright price target on EXEL, each point a stated target, August 2021 to September 2023.

Every H.C. Wainwright rating on EXEL

How other firms rate EXEL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsMarket Perform$54Aug 19, 2026
Leerink PartnersMarket Perform$52Aug 6, 2026
Truist SecuritiesHold$54Jun 25, 2026
Morgan StanleyEqual-Weight$48Jan 8, 2026
BofA SecuritiesUnderperform$41Jan 5, 2026
Wolfe ResearchPeer PerformNov 18, 2025

Questions about H.C. Wainwright and EXEL

What is H.C. Wainwright's price target for EXEL?
H.C. Wainwright's latest stated price target for Exelixis Inc. (EXEL) is $28, from its action on Sep 26, 2023.
What is H.C. Wainwright's rating on EXEL?
H.C. Wainwright rates EXEL Buy, a bullish rating, as of Sep 26, 2023.
When did H.C. Wainwright last change its view on EXEL?
On Sep 26, 2023, H.C. Wainwright starts coverage at Buy, price target $28.
How does H.C. Wainwright's EXEL target compare with other analysts?
Across 5 firms with a EXEL price target in the last 12 months, the median target is $52.

More EXEL rating histories

All H.C. Wainwright ratingsEXEL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.